<style>
  
#bubble {
top:40px;
right:0;
position:absolute;
display:block;
height:28px;
background:url(images/bubble_right.gif) no-repeat right;
}

#bubble p {
display:block;
font-size:11px;
color:#fff;
height:28px;
padding:4px 12px 0 10px;
background:url(images/bubble_left.gif) no-repeat top left;
}

#content {
margin-top: 20px;
background: #fff!important;
float:left;
/*width:578px;*/
width:71%;
}

#content h2 {
	color: #000;
	font-size: 18px;
	font-weight: 700;
}

#content h2 a {
text-decoration:none;
}

#content h2 a:hover {
text-decoration:underline;
}

#content h2.archive {
font-weight:normal;
font-size:22px;
color:#1c1c1c;
padding:0;
margin:5px 0 20px 0;
border:none;
text-align:left;
}

.comments {
color:#333;
margin:0 0 15px 0;
border-bottom:#bbb 1px solid;
}

.comments a {
background:#fff;
padding:0 7px 5px 0;
color:#333;
text-decoration:none;
}

.comments a:hover {
color:#c00;
}

.navigation {
background:#f9f9f9;
font-size:11px;
padding:5px 10px;
margin:0 0 20px 0;
border-top:#bbb 1px solid;
}

.navigation a {
color:#555;
font-weight:bold;
text-decoration:none;
}

.navigation a:hover {
color:#333;
text-decoration:none;
}

.main h3 {
font-size:16px;
font-weight:normal;
margin:0 0 15px 0;
}

.main img {
padding:2px;
border:#ddd 2px solid;
}

.main a img {
padding:2px;
border:#0085b5 2px solid;
}

.main a:hover img {
padding:2px;
border:#ca0002 2px solid;
}

.main p {
line-height:18px;
margin:0 0 15px 0;
}

.main ol {
line-height:18px;
margin:0 0 15px 30px;
}

.main ul {
line-height:18px;
margin:0 0 15px 30px;
}

.main li {
margin:0 0 5px 0;
}

.meta {
background:#f3f3f3;
font-size:11px;
line-height:15px;
color:#333;
padding:5px 10px;
margin:0 0 30px 0;
border-top:#bbb 1px solid;
}

.signature {
float:left;
padding:0 15px 0 0;
border-right:#bbb 1px solid;
width:200px;
}

.tags {
float:left;
padding:0 0 0 15px;
width:440px;
}

#sidebar {
background: #323232;
border-bottom-right-radius: 30px;
margin-top: 20px;
font-size:12px;
float:right;
width:284px;
padding: 15px;
color: white;
}

#sidebar a {
	color: #DBA922;
}

#sidebar h3 {
display: block;
color: white;
font-size:14px;
margin:20px 0 10px 0;
}

#sidebar ul {
list-style:none;
padding: 0 0 0 20px;
margin: 0;
}

#sidebar ul ul {
margin:5px 0 0 10px;
}

#sidebar ul ul ul {
margin:5px 0 0 10px;
}

#sidebar ul li {
padding: 0;
margin: 0;
}

#author h3 {
margin:5px 0 5px 0;
}

#searchform {
margin:15px 0 0 0;
}

#searchform input {
background:#222;
font-size:11px;
margin:2px 0;
padding:1px 4px 2px 4px;
border:#888 1px solid;
color:#eee;
}

#searchform input:hover {
background:#333;
border:#999 1px solid;
color:#fff;
cursor:pointer;
}

#searchform #s {
background:#f6f6f6;
font-size:11px;
margin:2px 0;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

#searchform #s:hover {
border:#c00 1px solid;
cursor:text;
}

input.searchfield {
background:#f6f6f6;
font-size:11px;
display:block;
margin:5px 0 8px 0;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

input.searchfield:hover {
background:#eee;
color:#222;
}

input.submit {
background:#222;
font-size:11px;
display:block;
margin:0 0 10px 0;
padding:1px 4px 2px 4px;
border:#888 1px solid;
color:#eee;
}

input.submit:hover {
background:#333;
cursor:pointer;
border:#999 1px solid;
color:#fff;
}

input.subcom {
background:#eee;
font-size:11px;
margin:0 0 10px 0;
padding:1px 4px 2px 4px;
border:#888 1px solid;
color:#222;
}

input.subcom:hover {
background:#222;
cursor:pointer;
border:#888 1px solid;
color:#eee;
}

input.comment {
background:#f6f6f6;
font-size:11px;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

input.comment:hover {
border:#c00 1px solid;
}

textarea {
background:#f6f6f6;
font-size:12px;
width:400px;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

textarea:hover {
border:#c00 1px solid;
}

.postinput small {
font-size:11px;
margin:0 0 0 5px;
}

p.logged {
font-size:12px;
}

h3.reply {
font-size:15px;
margin:0 0 10px 0;
}

.nocomments {
margin:0 0 30px 0;
}

ol.commentlist {
font-size:12px;
list-style:none;
margin:10px 0 30px 0;
border-bottom:#bbb 1px solid;
}

.commentlist li {
border-top:#bbb 1px solid;
padding:0 0 10px 0;
}

.commentlist li.bypostauthor {
border-top:#bbb 5px solid;
background-color:#f3f3f3;
}

.comment_mod {
margin:10px 0 0 10px;
}

.comment_mod em {
background-color:#fff897;
padding:1px 3px;
}

.comment_author {
margin:10px 0;
float:right;
width:190px;
}

.comment_author img {
float:left;
margin:5px 12px 0 0;
}

.comment_author p {
line-height:20px;
}

.comment_author small {
font-size:11px;
}

.comment_text {
float:left;
width:470px;
margin:0 0 0 10px;
}

.comment_text p {
line-height:18px;
margin:7px 0;
}

.comment_meta {
font-size:12px;
}

#commentform p {
line-height:18px;
margin:0 0 15px 0;
}

blockquote {
background:url(images/quote.gif) no-repeat top left;
padding:0 0 0 60px;
min-height:50px;
}

.clear {
clear:both;
}

.warning p {
background:url(images/warning.gif) no-repeat left;
height:160px;
padding:20px 0 0 90px;
font-size:20px;
margin:0 0 0 10px;
}

#wp-calendar {
padding:10px 0 0 0;
font-size:12px;
}

#wp-calendar caption {
text-align:left;
padding:0 0 5px 0;
}

#wp-calendar tr th,
#wp-calendar tr td {
padding:0 6px 0 0 ;
text-align:right;
}

#wp-calendar td a {
font-weight:bold;
}

#wp-calendar td a:hover {
font-weight:bold;
}

img.wp-smiley {
padding:0;
border:none;
}

input:focus, textarea:focus{
background-color:#ffc;
}

abbr {
border:none;
}

.aligncenter {
display: block;
margin-left: auto;
margin-right: auto;
}

.alignleft {
float:left;
}

.alignright {
float:right;
}

.wp-caption {
border:1px solid #ddd;
text-align:center;
background-color:#f3f3f3;
padding-top:4px;
margin:10px;
-moz-border-radius:3px;
-khtml-border-radius:3px;
-webkit-border-radius:3px;
border-radius:3px;
}

.wp-caption img {
margin:0;
padding:0;
border:0 none;
}

.wp-caption-dd {
font-size:11px;
line-height:17px;
padding:0 4px 5px;
margin:0;
}

/* self-clear floats */

.group:after {
content: "."; 
display: block; 
height: 0; 
clear: both; 
visibility: hidden;
}
#content.group .main img{display:none!important;}
#cas_menu{display:none!important;}
#cas_menu ul li a{height:auto!important;}

  </style>
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Westport CT Medical Malpractice Lawyer &#124; Rich Raphael Attorney Blog &#187; Essure device</title>
	<atom:link href="https://www.raphaellaw.com/personal-injury-blog/tag/essure-device/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.raphaellaw.com/personal-injury-blog</link>
	<description></description>
	<lastBuildDate>Sat, 31 Oct 2020 11:46:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.1.38</generator>
	<item>
		<title>FDA to Investigate Safety of Essure Birth Control</title>
		<link>https://www.raphaellaw.com/personal-injury-blog/2015/08/06/safety-of-essure-birth-control/</link>
		<comments>https://www.raphaellaw.com/personal-injury-blog/2015/08/06/safety-of-essure-birth-control/#comments</comments>
		<pubDate>Thu, 06 Aug 2015 16:11:36 +0000</pubDate>
		<dc:creator><![CDATA[Staff Writer]]></dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Product Defects]]></category>
		<category><![CDATA[birth control side effects]]></category>
		<category><![CDATA[Essure device]]></category>
		<category><![CDATA[product defects]]></category>
		<category><![CDATA[safety of essure birth control]]></category>
		<category><![CDATA[Westport personal injury attorney]]></category>

		<guid isPermaLink="false">https://www.raphaellaw.com/personal-injury-blog/?p=904</guid>
		<description><![CDATA[<p>Reports of serious concerns over a popular contraceptive, used by countless women, is coming under federal review due to multiple reports of dangerous medical complications suffered by women who have used the device. The Food and Drug Administration (FDA) has announced that they are reviewing the safety of the implant Essure. The contraceptive device is manufactured by Bayer [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog/2015/08/06/safety-of-essure-birth-control/">FDA to Investigate Safety of Essure Birth Control</a> appeared first on <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog">Westport CT Medical Malpractice Lawyer | Rich Raphael Attorney Blog</a>.</p>
]]></description>
				<content:encoded><![CDATA[<p><img class="alignright wp-image-926 size-medium" style="margin: 5px;" src="https://www.raphaellaw.com/personal-injury-blog/wp-content/uploads/2015/08/birth-control-safety-Connecticut-300x200.jpg" alt="birth control safety, safety of essure birth control, Westport Personal Injury Lawyer" width="300" height="200" />Reports of serious concerns over a popular contraceptive, used by countless women, is coming under federal review due to multiple reports of <a href="https://www.raphaellaw.com/medical-malpractice">dangerous medical complications</a> suffered by women who have used the device.</p>
<p>The <a href="http://www.nbcnewyork.com/news/local/Essure-FDA-New-Public-Review-Complaints-Complications-Birth-Control-Device-310161461.html" target="_blank">Food and Drug Administration (FDA)</a> has announced that they are reviewing the safety of the implant Essure. The contraceptive device is manufactured by Bayer and has been on the market since 2002. The device is made of two metal coils which are inserted into the fallopian tubes as a way to block contraception.</p>
<p>However, the FDA says that they have received more than 5,000 complaints of medical issues, including abdominal pain, fatigue, headaches, and weight fluctuations, by female patients prescribed Essure since its approval. More than 400 women and/or their doctors have reported the coils moving away from the fallopian tubes and into other parts of the patient’s reproductive system.</p>
<p>There have also been reports of five fetal deaths, which occurred when the Essure device failed to prevent pregnancy.</p>
<p>Since its approval, the Essure device has been implanted into approximately 750,000 women. Based on the number of complaints the FDA has received, this means approximated one in every 150 women has had a problem with the device.</p>
<p>The FDA has scheduled a public hearing to be held on September 24, 2015 to review the safety of the product. The hearing will include the agency’s Obstetrics and Gynecology Devices Panel. This hearing is being scheduled due in part to a <a href="http://www.nbcnewyork.com/investigations/Essure-Birth-Control-FDA-Pain-Studies-I-Team.html" target="_blank">New York television news channel’s investigation</a> regarding the inconsistencies which took place during the clinical trials of Essure. These trials, which failed to disclose complaints by trial patients, were presented to the FDA in order to get the agency’s approval for the device.</p>
<p>If you have experienced medical complications or other issues from having the Essure device implanted, or any other medical device issues, contact an experienced <a href="https://www.raphaellaw.com/contact">Westport personal injury attorney</a> to find out what legal recourse you may have for your pain and loss. For a free initial consultation about your case, call Attorney Richard H. Raphael at 203-226-6168 today.</p>
<p>The post <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog/2015/08/06/safety-of-essure-birth-control/">FDA to Investigate Safety of Essure Birth Control</a> appeared first on <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog">Westport CT Medical Malpractice Lawyer | Rich Raphael Attorney Blog</a>.</p>
]]></content:encoded>
			<wfw:commentRss>https://www.raphaellaw.com/personal-injury-blog/2015/08/06/safety-of-essure-birth-control/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
